Canada: First Preparatory Session; Second and Third Subjects Enrolled

In 2006—over eight years ago—MAPS begin working to start MDMA-assisted psychotherapy for PTSD research in Canada. Finally and after enormous effort, on January 2, 2015, the first preparatory psychotherapy session took place for the first subject in our new Canadian study of MDMA-assisted psychotherapy for PTSD in Vancouver, BC. The second and third subjects were enrolled on December 23, 2014. Led by Principal Investigator Ingrid Pacey, M.D., and co-therapists Donna Dryer, M.D., and Richard Yensen, Ph.D., in Vancouver, B.C., this study will treat up to 12 subjects with chronic, treatment-resistant PTSD from any cause. This is the first Health Canada-approved clinical psychedelic research to take place in over 40 years. Learn more | Donate to help complete this study